AU4248400A - Single-dose antihistamine/decongestant formulations for treating rhinitis - Google Patents

Single-dose antihistamine/decongestant formulations for treating rhinitis

Info

Publication number
AU4248400A
AU4248400A AU4248400A AU4248400A AU4248400A AU 4248400 A AU4248400 A AU 4248400A AU 4248400 A AU4248400 A AU 4248400A AU 4248400 A AU4248400 A AU 4248400A AU 4248400 A AU4248400 A AU 4248400A
Authority
AU
Australia
Prior art keywords
decongestant
formulations
treating rhinitis
antihistamine
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4248400A
Inventor
Robert E Weinstein
Allan M Weinstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
J-Med Pharmaceuticals Inc
Original Assignee
J-Med Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J-Med Pharmaceuticals Inc filed Critical J-Med Pharmaceuticals Inc
Publication of AU4248400A publication Critical patent/AU4248400A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU4248400A 2000-04-14 2000-04-14 Single-dose antihistamine/decongestant formulations for treating rhinitis Pending AU4248400A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/010328 WO2001078782A1 (en) 2000-04-14 2000-04-14 Single-dose antihistamine/decongestant formulations for treating rhinitis

Publications (1)

Publication Number Publication Date
AU4248400A true AU4248400A (en) 2001-10-30

Family

ID=21741287

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4248400A Pending AU4248400A (en) 2000-04-14 2000-04-14 Single-dose antihistamine/decongestant formulations for treating rhinitis
AU2000242484A Ceased AU2000242484B2 (en) 2000-04-14 2000-04-14 Single-dose antihistamine/decongestant formulations for treating rhinitis

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2000242484A Ceased AU2000242484B2 (en) 2000-04-14 2000-04-14 Single-dose antihistamine/decongestant formulations for treating rhinitis

Country Status (5)

Country Link
EP (1) EP1276502A1 (en)
JP (1) JP5592042B2 (en)
AU (2) AU4248400A (en)
CA (1) CA2405238C (en)
WO (1) WO2001078782A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020055A1 (en) * 2000-05-25 2002-02-12 Schering Corp STABLE LIQUID AND SOLID FORMULATIONS INCLUDING A NON-SEDATING ANTIHISTAMINE AND A NASAL DECONGESTANT
JP2004026810A (en) * 2002-05-07 2004-01-29 Rohto Pharmaceut Co Ltd Composition for rhinitis
JP4320217B2 (en) * 2002-07-10 2009-08-26 剤盛堂薬品株式会社 Oral preparation for rhinitis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
TR199901003T2 (en) * 1996-10-31 1999-07-21 Schering Corporation Composition containing loratadine and a decongestant for the treatment of asthma.
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup

Also Published As

Publication number Publication date
WO2001078782A1 (en) 2001-10-25
CA2405238C (en) 2014-03-18
JP5592042B2 (en) 2014-09-17
JP2003532642A (en) 2003-11-05
CA2405238A1 (en) 2001-10-25
EP1276502A1 (en) 2003-01-22
AU2000242484B2 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
EP1261370A4 (en) Therapeutic method for reducing angiogenesis
GB0012671D0 (en) Therapeutic agents
GB0003397D0 (en) Therapeutic agents
GB0004003D0 (en) Therapeutic agents
EP1296697A4 (en) Therapeutic agents - i
GB0023983D0 (en) Therapeutic compounds
GB0008710D0 (en) Therapeutic compounds
GB0017256D0 (en) Therapeutic agents
GB0016681D0 (en) Therapeutic compounds
GB0027561D0 (en) Therapeutic agents
GB0005789D0 (en) Therapeutic agents
GB0007907D0 (en) Therapeutic agents
GB0012214D0 (en) Therapeutic agents
GB0008696D0 (en) Therapeutic agents
GB0000564D0 (en) Therapeutic agents
GB0023610D0 (en) Therapeutic agents
GB0020721D0 (en) Therapeutic agents
GB0009612D0 (en) Therapeutic formulations
GB0017518D0 (en) Therapeutic agents
AU4248400A (en) Single-dose antihistamine/decongestant formulations for treating rhinitis
GB0007376D0 (en) Therapeutic agents
GB0017543D0 (en) Therapeutic agents
GB0022988D0 (en) Therapeutic agents
GB0013105D0 (en) Therapeutic compounds
GB0012709D0 (en) Therapeutic agents